February 28, 2024 (Korea Bizwire) Proposal to appoint Ms. Hanneman as member of Philips’ Board of Management fulfilling the role of CFO per October 1, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the proposal to appoint Charlotte Hanneman as member of the Board of Management, [...]
February 27, 2024 (Korea Bizwire) New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced major enhancements to its Image Guided Therapy System – [...]
VANCOUVER, British Columbia, Feb. 27, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: TD Cowen 44th Annual Health Care Conference: Zymeworks’ management will [...]
Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expense SAN DIEGO, Feb. 26, 2024 (Korea Bizwire) – Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible and rapid automated [...]
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis (MASH)*, after meeting its primary and key secondary endpoint following 48 weeks of treatment versus placebo in a Phase II trial Survodutide, a novel glucagon/GLP-1 receptor dual agonist, has demonstrated efficacy in people with obesity1, and statistically significant results in MASH2 suggest the potential to [...]
ALBANY, N.Y., Feb. 23, 2024 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services. “This is an exciting time for our biologics team, and [...]
Embark on a Journey of Cutting-Edge Treatments and Research Collaboration KUALA LUMPUR, Malaysia, Feb. 21 (Korea Bizwire) — As the world marks Cancer Awareness Month, Malaysia has made significant strides in the field of cancer treatment, earning recognition as a premier destination for individuals seeking advanced care. With its state-of-the-art medical facilities, renowned healthcare professionals, [...]
February 20, 2024 (Korea Bizwire) 1.88 billion lives improved by Philips’ health technology products and services; on track to improve 2 billion lives by 2025 Through its industry leading innovations and partnerships, Philips helps increase access to healthcare globally and create sustainable and resilient healthcare models Philips expanded its circular revenues to 20% of sales; remained [...]
February 20, 2024 (Korea Bizwire) Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it proposes to re-appoint Chairman Feike Sijbesma and Peter Löscher as members of the Supervisory Board and to appoint Benoît Ribadeau-Dumas as new member of the Supervisory Board to the Annual General Meeting [...]
February 20, 2024 (Korea Bizwire) Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2023. Philips’ Annual Report 2023 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 7, 2024. The convocation notice and the agenda, [...]